The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Case series of EGFR C797S mutations in non-small cell lung cancer identified with cell-free circulating tumor DNA next generation sequencing.
 
Stephen R Fairclough
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Oliver A. Zill
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Darya Chudova
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Christine Elaine Lee
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Richard Burnham Lanman
Employment - Guardant Health; Veracyte
Stock and Other Ownership Interests - Guardant Health; Veracyte
 
Kimberly C. Banks
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Rebecca J Nagy
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Stefanie Mortimer
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Helmy Eltoukhy
Employment - Guardant Health
Leadership - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Guardant Health
 
AmirAli Talasaz
Employment - Guardant Health
Leadership - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Guardant Health
 
Suresh S. Ramalingam
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly/ImClone; Merck; Novartis
Travel, Accommodations, Expenses - AstraZeneca; EMD Serono; Pfizer